(Q39846278)

15 September 2017

title

Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery (English)

1 reference

15 September 2017

1 reference

Leslie Bell

1

1 reference

15 September 2017

Shari Bickford

2

1 reference

15 September 2017

Phong Hung Nguyen

3

1 reference

15 September 2017

Jianling Wang

4

1 reference

15 September 2017

Timothy He

5

1 reference

15 September 2017

Bailin Zhang

6

1 reference

15 September 2017

Yannick Friche

7

1 reference

15 September 2017

Alfred Zimmerlin

8

1 reference

15 September 2017

Laszlo Urban

9

1 reference

15 September 2017

Dejan Bojanic

10

1 reference

15 September 2017

publication date

12 May 2008

1 reference

Journal of Biomolecular Screening

15 September 2017

published in

1 reference

15 September 2017

volume

13

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

343-353

1 reference

The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Predicting in vivo drug interactions from in vitro drug discovery data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--towards a consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

CYP3A4 drug interactions: correlation of 10 in vitro probe substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

Effects of ionic strength on the functional interactions between CYP2B4 and CYP1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057108317480

21 January 2018

Identifiers

DOI

10.1177/1087057108317480

1 reference

15 September 2017

1 reference